| pubmed-article:222690 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:222690 | lifeskim:mentions | umls-concept:C0014644 | lld:lifeskim |
| pubmed-article:222690 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:222690 | lifeskim:mentions | umls-concept:C0010453 | lld:lifeskim |
| pubmed-article:222690 | lifeskim:mentions | umls-concept:C0023516 | lld:lifeskim |
| pubmed-article:222690 | lifeskim:mentions | umls-concept:C1179435 | lld:lifeskim |
| pubmed-article:222690 | lifeskim:mentions | umls-concept:C0020964 | lld:lifeskim |
| pubmed-article:222690 | lifeskim:mentions | umls-concept:C0684321 | lld:lifeskim |
| pubmed-article:222690 | lifeskim:mentions | umls-concept:C1705248 | lld:lifeskim |
| pubmed-article:222690 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:222690 | lifeskim:mentions | umls-concept:C1548799 | lld:lifeskim |
| pubmed-article:222690 | lifeskim:mentions | umls-concept:C1524073 | lld:lifeskim |
| pubmed-article:222690 | lifeskim:mentions | umls-concept:C0449432 | lld:lifeskim |
| pubmed-article:222690 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:222690 | pubmed:dateCreated | 1979-9-17 | lld:pubmed |
| pubmed-article:222690 | pubmed:abstractText | Regression of EB-virus-induced transformation occurs exclusively in cultures of leukocytes from seropositive donors. Studies have shown that the strength of regression could be assayed in terms of the proportion of T cells which must be added to the autologous EB virus-infected T-cell-depleted population in order to establish regression in the culture. The in vitro regression phenomenon was strongly T-cell-dependent but did not require the presence of either monocytes or, as a potential antigenic stimulus, the residual viral envelope material on the surface of virus-infected B cells. The T-cell-depleted population from seropositive donors sometimes transformed (7/60 cultures) without the experimental addition of virus. Regression appeared to be independent of cytotoxic mechanisms involving anti-viral antibodies and not to be mediated by soluble factors released into culture medium. | lld:pubmed |
| pubmed-article:222690 | pubmed:language | eng | lld:pubmed |
| pubmed-article:222690 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:222690 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:222690 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:222690 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:222690 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:222690 | pubmed:month | May | lld:pubmed |
| pubmed-article:222690 | pubmed:issn | 0020-7136 | lld:pubmed |
| pubmed-article:222690 | pubmed:author | pubmed-author:PopeJ HJH | lld:pubmed |
| pubmed-article:222690 | pubmed:author | pubmed-author:MossD JDJ | lld:pubmed |
| pubmed-article:222690 | pubmed:author | pubmed-author:RickinsonA... | lld:pubmed |
| pubmed-article:222690 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:222690 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:222690 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:222690 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:222690 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:222690 | pubmed:pagination | 610-7 | lld:pubmed |
| pubmed-article:222690 | pubmed:dateRevised | 2007-7-24 | lld:pubmed |
| pubmed-article:222690 | pubmed:meshHeading | pubmed-meshheading:222690-H... | lld:pubmed |
| pubmed-article:222690 | pubmed:meshHeading | pubmed-meshheading:222690-P... | lld:pubmed |
| pubmed-article:222690 | pubmed:meshHeading | pubmed-meshheading:222690-L... | lld:pubmed |
| pubmed-article:222690 | pubmed:meshHeading | pubmed-meshheading:222690-M... | lld:pubmed |
| pubmed-article:222690 | pubmed:meshHeading | pubmed-meshheading:222690-A... | lld:pubmed |
| pubmed-article:222690 | pubmed:meshHeading | pubmed-meshheading:222690-T... | lld:pubmed |
| pubmed-article:222690 | pubmed:meshHeading | pubmed-meshheading:222690-C... | lld:pubmed |
| pubmed-article:222690 | pubmed:meshHeading | pubmed-meshheading:222690-L... | lld:pubmed |
| pubmed-article:222690 | pubmed:meshHeading | pubmed-meshheading:222690-C... | lld:pubmed |
| pubmed-article:222690 | pubmed:meshHeading | pubmed-meshheading:222690-A... | lld:pubmed |
| pubmed-article:222690 | pubmed:meshHeading | pubmed-meshheading:222690-H... | lld:pubmed |
| pubmed-article:222690 | pubmed:meshHeading | pubmed-meshheading:222690-T... | lld:pubmed |
| pubmed-article:222690 | pubmed:year | 1979 | lld:pubmed |
| pubmed-article:222690 | pubmed:articleTitle | Long-term C-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures. | lld:pubmed |
| pubmed-article:222690 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:222690 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:222690 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:222690 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:222690 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:222690 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:222690 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:222690 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:222690 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:222690 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:222690 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:222690 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:222690 | lld:pubmed |
